6533b881fe1ef96bd12d81c7
RESEARCH PRODUCT
One-Year of Dapaglifozin Add-On Therapy Ameliorates Surrogate Indexes of Insulin Resistance and Adiposity in Patients with Type 2 Diabetes Mellitus
Adis Journals On Behalf OfStefano RadelliniEnrica VigneriValentina GuarnottaFelicia PantoCarla Giordanosubject
description
Article full text The above summary slide represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite). © The authors, CC-BY-NC 2021.
year | journal | country | edition | language |
---|---|---|---|---|
2021-01-01 |